Is lagundi syrup safe for individuals with Glucose-6-phosphate dehydrogenase (G6PD) deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lagundi Syrup Safety in G6PD Deficiency

Lagundi syrup can be used safely in individuals with G6PD deficiency, as there is no evidence contraindicating its use.

Evidence-Based Medication Classification in G6PD Deficiency

The most comprehensive and recent evidence systematically categorizes medications into risk levels for G6PD-deficient patients. Only seven medications have solid evidence for absolute contraindication 1, 2:

  • High-risk medications to avoid completely:
    • Dapsone 1, 2
    • Methylene blue (methylthioninium chloride) 1, 2
    • Primaquine 1, 2
    • Rasburicase 3, 2
    • Nitrofurantoin 2
    • Phenazopyridine 2
    • Tolonium chloride 2

Lagundi (Vitex negundo) Status

Lagundi syrup is not listed among contraindicated medications in any guideline or evidence-based review of G6PD deficiency 1, 3, 2, 4.

Supporting Evidence for Herbal Products

A systematic review specifically examining herbal and dietary supplements in G6PD deficiency found 5:

  • Only henna showed evidence of causing hemolysis 5
  • Most herbal products had insufficient evidence to contravene their use at therapeutic doses 5
  • Vitamin C, vitamin E, vitamin K, Ginkgo biloba, and α-lipoic acid showed no evidence of harm 5

Real-World Safety Data

A large real-world study of 31,962 G6PD-deficient patients demonstrated 6:

  • Only 71 cases (0.2%) experienced major hemolysis requiring hospitalization 6
  • 71.8% of hemolytic episodes were caused by fava beans, not medications 6
  • Only 3 cases (4.2%) were potentially medication-related 6
  • Many previously suspected medications were prescribed safely to thousands of G6PD-deficient patients 6

Clinical Approach

Since lagundi is not among the seven definitively contraindicated medications and no case reports or evidence link it to hemolysis in G6PD deficiency, it can be prescribed with standard precautions 2, 4.

Important Caveats

  • Monitor for signs of hemolysis when starting any new medication, including jaundice, dark urine, or pallor 3
  • The most common trigger for hemolysis in G6PD-deficient patients is fava bean ingestion, not medications 6
  • Many medications have been wrongly cited as causing hemolysis because they were given during infection-related hemolytic episodes 2

References

Guideline

Medications Contraindicated in G6PD Deficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of G6PD Deficiency in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.